Ernest Mario

Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.

IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections.

Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ

Metalmark Capital LLC (Metalmark Capital) is a private equity firm founded by John J. Moon in 1986. The firm is headquartered in New York.

Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA.

Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC.

Avid Radiopharmaceuticals, Inc. provides molecular imaging services. It develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company was founded by Daniel M. Skovronsky in 2004 and is headquartered in Philadelphia, PA.

TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA.

TAXIS Pharmaceuticals, Inc develops antibiotics for the treatment of multidrug-resistant bacteria. The company was founded by Edmond J. LaVoie, Gregory G. Mario and Daniel S. Pilch in 2009 and is headquartered in Monmouth Junction, NJ.

Delpor, Inc. develops therapeutic products. Its products include DLP-114, DLP-119, DLP-202 and DLP-414. The company was founded by Tassos Nicolaou and Frank Martin in 2009 and is headquartered in San Francisco, CA.

TONIX Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Seth Lederman and Daniel L. Kreisler on June 7, 2007 and is headquartered in New York, NY.

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.

Duke University Health System, Inc. engages in the provision of health care services. It offers cancer treatment, primary care, orthopedics, aesthetics, and fertility services. The company was founded in 1998 and is headquartered in Durham, NC.

Part of AstraZeneca PLC, Apothogen, Inc. is a private company that develops and markets pharmaceuticals. The company is based in Raleigh, NC. Apothogen was acquired by IntraBiotics Pharmaceuticals, Inc. on April 24, 2002 for $1.81 million.

Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina.

XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA.

Linden Manager LLC (Linden Capital Partners) is a private equity firm founded in 2004 by Anthony B Davis and Brain C Miller. The firm is headquartered in Chicago, Illinois.

The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC.

Rutgers University Foundation is the fundraising arm of Rutgers University. The foundation build relationships with alumni and friends, corporations, and foundations and seek their support of Rutgers programs throughout New Jersey and the world. It was founded in 1973 and it is headquartered in New Brunswick, NJ.

Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom.

Part of Bristol Myers Squibb Co., Celgene, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases. The Canadian company's portfolio includes several approved products, such as REVLIMID, POMALYST, and OTEZLA, as well as a pipeline of investigational drugs. Celgene is committed to advancing the science of medicine and improving the lives of patients worldwide.

Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA.

Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.

Amplitude Healthcare Acquisition Corp. operates as a blank check company. It aims to acquire one or more businesses and assets through a merger, share purchase and reorganization. The company was founded on August 13, 2019 and is headquartered in New York, NY.

Capnia, Inc. develops diagnostics and devices to address unmet medical needs. Its CoSense® End-Tidal Carbon Monoxide Monitor product measures end-tidal carbon monoxide (ETCO) for the detection of dangerous hemolysis rates. The company is headquartered in Foster City, CA.